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Primary  cicatricial  alopecias  (PCA)  are  a  diverse  group  of
inﬂammatory  hair  disorders  of  unknown  aetiology,  clinically
characterised  by  the  loss  of  hair  shafts,  visible  follicular
ostia,  and  variable  degrees  of  scalp  inﬂammation.  The  hair
follicle  is  the  primary  target  of  the  disease  process  and  per-
sistent  inﬂammation  leads  to  irreversible  damage  to  the
hair  follicle’s  stem  cells.  Ultimately,  replacement  of  follic-
ular  structures  by  scar-like  ﬁbrous  tissue  occurs.1--3 Frontal
ﬁbrosing  alopecia  (FFA)  is  one  of  the  most  common  types  of
PCA.  The  clinical  diagnosis  is  typically  straightforward;  FFA  is
considered  to  be  a  subtype  of  lichen  planopilaris  (LPP)  and
is  based  on  similar  histopathological  ﬁndings.4,5 An  effec-
tive  medical  treatment  remains  elusive  and  evidence-based
recommendations  are  weak:  intralesional  triamcinolone
acetonide,  ﬁnasteride,  dutasteride,  oral  and  topical  corti-
costeroids  (level  of  evidence  D),  and  antimalarials  (level  of
evidence  E).1,5,6 Despite  medical  treatment,  the  course  of
FFA  is  uncertain  and,  in  the  best  scenario,  these  drugs  can
only  stop  disease  progression.1 In  daily  practice,  we  have
observed  that  the  cosmetic  impact  of  FFA  on  women  is  a
frequent  cause  of  anxiety,  and  just  halting  the  alopecia  pro-
cess  is  generally  not  sufﬁcient  in  most  cases.  Some  patients
with  FFA  insistently  demand  a  hair  transplant  despite  being
properly  informed  of  the  high  risk  of  hair  loss  a  few  months
after  the  procedure.How  could  hair  transplantation  be  part  of  the  solution
for  FFA?  Literature  regarding  hair  transplantation  for  FFA  is
scarce.  Publications  by  Nusbaum  et  al.  and  Jiménez  et  al.
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or  1.5--2  years  after  transplantation,  more  than  50%  of
he  transplanted  hairs  had  been  lost  after  3  years.  Histo-
ogical  conﬁrmation  of  FFA  in  the  remaining  transplanted
ollicles  suggests  that  FFA  displays  recipient  dominance.
ost-transplant  medical  therapy  is  not  mentioned  in  either
f  the  publications.6,7 Gurﬁnkiel  et  al.  reported  a  successful
ase  of  hair  transplantation  in  a  female  patient  with  FFA  and
ulvar  lichen  sclerosus  with  a  follow-up  of  6  years,  maintain-
ng  systemic  ﬁnasteride  1  mg/day  and  topical  minoxidil  2%
id  as  post-transplant  maintenance  therapy.8
Unger  et  al.  have  recently  proposed  two  new  categories
f  cicatricial  alopecia:  unstable  and  stable.  Unstable  cicatri-
ial  alopecias  (UCA)  have  a  tendency  to  progress  and  recur
ntermittently  over  the  course  of  time,  in  either  new  or
reviously  affected  areas  (e.g.,  discoid  cutaneous  lupus  ery-
hematous,  LPP).  Stable  cicatricial  alopecias  are  secondary
o  isolated  events  that  cause  permanent  scarring  in  a  hair-
earing  region  (e.g.,  burn,  surgical  scar);  once  successfully
orrected  surgically,  there  is  no  need  for  further  therapy.9
he  chronic  and  relapsing  nature  of  FFA,  even  after  hair
ransplantation,  is  the  paradigm  of  UCA.  It  has  become  clear
hat  this  procedure  can  only  be  considered  for  FFA  after  a
ertain  period  of  observation  with  no  disease  activity,  and
ecommendations  range  from  1  to  5  years6--8; we  do  not
sually  consider  hair  transplantation  in  FFA  until  2  years  of
linical  stability  have  been  observed.  However,  once  hair
ransplantation  has  been  performed,  these  patients  should
e  kept  on  maintenance  medical  treatment  for  affected
reas,  even  if  no  clinical  signs  of  disease  activity  are  visible.
he  usefulness  of  performing  trichoscopy  to  monitor  dis-
ase  activity  and  response  to  therapy  cannot  be  emphasised
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cial alopecia. Dermatol Ther. 2008;21:295--311.
10. Toledo-Pastrana T, Hernández M, Camacho Martínez F. Perifol- 
nough:  look  for  the  presence  of  perifollicular  hyperker-
tosis/desquamation  and  perifollicular  erythema,  which  are
orrelated  with  disease  activity  in  FFA.10
Regarding  the  maintenance  medical  treatment  to  be
rescribed  after  hair  transplantation  for  FFA,  clobetasol
ropionate  0.05%  lotion  twice  a  week  could  be  consid-
red  as  a  possible  maintenance  scheme;  from  our  clinical
ractice  experience,  the  risk  of  adverse  effects  with  this
egimen  appears  to  be  very  small.  As  an  alternative,  a
opical  calcineurin  inhibitor  such  as  tacrolimus  0.1%  oint-
ent  or  pimecrolimus  1%  cream  could  also  be  considered
tolerability:  pimecrolimus  >  tacrolimus).  In  our  experience,
aintaining  concomitant  post-transplant  therapy  with  sys-
emic  ﬁnasteride  5  mg/day  and  topical  minoxidil  5%  is  also
dvisable,  particularly  if  androgenetic  alopecia  is  concomi-
antly  present.  Dutasteride  has  been  recently  attempted
s  an  alternative  to  ﬁnasteride;  although  dutasteride  might
ppear  at  least  equally  effective,  its  superiority  and  more
avourable  safety  proﬁle  are  not  yet  proven.  Follow-up  visits
hould  be  frequent,  and  more  aggressive  anti-inﬂammatory
herapy  must  be  initiated  in  case  of  clinical  relapse,  not  only
o  ‘‘protect’’  transplanted  hairs  but  also  to  prevent  alopecia
rogression  to  previously  uninvolved  areas.
To  summarise,  the  need  for  post-transplant  medical  ther-
py  for  FFA  is,  in  our  opinion,  absolutely  decisive  for  the
uccess  of  the  transplantation.  Prior  to  surgery,  two  require-
ents  for  FFA  hair  transplantation  must  be  met:  2  years  of
linical  stability  and  the  patient’s  commitment  to  follow-
p  visits  and  adherence  to  post-transplant  medical  therapy.
trong  evidence-based  recommendations  for  the  medical
nd  surgical  treatment  of  FFA  are  warranted.
Downloaded for Anonymous User (n/a) at Centro Hospitalar Lisboa Central from Clini
For personal use only. No other uses without permission. Copyright ©2018P.  Mendes-Bastos,  A.  Camps-Fresneda
eferences
1. Harries MJ, Sinclair RD, Whiting DA, Grifﬁths CEM, Paus R. Mana-
gement of primary cicatricial alopecias: options for treatment;
2008. p. 1--22.
2. Stenn KS, Cotsarelis G, Price VH. Report from the cicatricial
alopecia colloquium. J Investig Dermatol. 2006;126:539--41.
3. Mobini N, Tam S, Kamino H. Possible role of the bulge region
in the pathogenesis of inﬂammatory scarring alopecia: lichen
plano-pilaris as the prototype. J Cutan Pathol. 2005;32:675--9.
4. Poblet E, Jimenez F, Pascual A, Pique E. Frontal ﬁbrosing alope-
cia versus lichen planopilaris: a clinicopathological study. Int J
Dermatol. 2006;45:375--80.
5. Molina-Ruiz S, Van˜ó-Galván AM, Serrano-Falcón C, Arias-
Santiago S, Rodrigues-Barata AR. Frontal ﬁbrosing alopecia:
a multicenter review of 355 patients. J Am Acad Dermatol.
2014;70:670--8.
6. Ladizinski B, Bazakas A, Selim M, Olsen E. Frontal ﬁbrosing
alopecia: a retrospective review of 19 patients seen at Duke
University. J Am Acad Dermatol. 2013;68:749--55.
7. Nusbaum B, Nusbaum A. Frontal ﬁbrosing alopecia in a
man: results of follicular unit test grafting. Dermatol Surg.
2010;36:959--62.
8. Jiménez F, Poblet E. Is hair transplantation indicated in frontal
ﬁbrosing alopecia? The results of test grafting in three patients.
Dermatol Surg. 2013;39:1115--8.
9. Unger W,  Unger R, Wesley C. The surgical treatment of cicatri-licular erythema as a trichoscopy sign of progression in frontal
ﬁbrosing alopecia. Int J Trichol. 2013;5:151--3.
calKey.com by Elsevier on February 02, 2018.
. Elsevier Inc. All rights reserved.
